Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Acta Neurol Scand Suppl ; 176: 6-11, 2000.
Article in English | MEDLINE | ID: mdl-11261807

ABSTRACT

Presenilin (PS1 and PS2) holoproteins are transiently incorporated into low molecular weight (MW) complexes. During subsequent incorporation into a higher MW complex, they undergo endoproteolysis to generate stable N- and C-terminal fragments (NTF/CTF). Mutation of either of two conserved aspartate residues in transmembrane domains inhibits both presenilin-endoproteolysis and the proteolytic processing of APP and Notch. We show that aspartate-mutant holoprotein presenilins are not incorporated into the high molecular weight, NTF/CTF-containing complexes. Aspartate-mutant presenilin holoproteins also preclude entry of endogenous wild-type PS1/PS2 into the high molecular weight complexes, but do not affect the incorporation of wild-type holoproteins into lower molecular weight holoprotein complexes. These data suggest that the loss-of-function aspartate-mutants cause altered PS complex maturation, and argue that the functional presenilin moieties are contained in the high molecular weight presenilin NTF/CTF-containing complexes.


Subject(s)
Alzheimer Disease/physiopathology , Aspartic Acid/metabolism , Membrane Proteins/genetics , Point Mutation , Amyloid Precursor Protein Secretases , Amyloid beta-Peptides/metabolism , Animals , Aspartic Acid/analogs & derivatives , Aspartic Acid/genetics , Aspartic Acid Endopeptidases , Cell Culture Techniques , Cell Membrane , DNA, Complementary/genetics , Endopeptidases/metabolism , Gene Expression Regulation , Humans , Membrane Proteins/metabolism , Mice , Presenilin-1 , Presenilin-2 , Protein Conformation
SELECTION OF CITATIONS
SEARCH DETAIL